{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:51:05Z","timestamp":1792803065183,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"vor","delay-in-days":1597,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Roche, Critical Diagnostics, BG Medicine, Siemens, Singulex, Novartis, Amgen, Zensun, and Thermo Fisher Scientific"},{"name":"National Institutes of Health and the Howard Hughes Medical Institute"},{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jchf.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T09:01:08Z","timestamp":1382605268000},"page":"480-487","source":"Crossref","is-referenced-by-count":118,"title":["Effects of Losartan on Left Ventricular Hypertrophy and Fibrosis in Patients With Nonobstructive Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"1","author":[{"given":"Yuichi J.","family":"Shimada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Passeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron L.","family":"Baggish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"O'Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Lowry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gia","family":"Yannekis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhny","family":"Abbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian B.","family":"Ghoshhajra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn Y.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Fifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2013.09.001_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1996.03540030033028","article-title":"Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles","volume":"276","author":"Maron","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2013.09.001_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/heart.84.5.476","article-title":"Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease","volume":"84","author":"Varnava","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2013.09.001_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(00)04005-8","article-title":"Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy","volume":"357","author":"Elliott","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2013.09.001_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0735-1097(02)02713-4","article-title":"Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy","volume":"41","author":"Olivotto","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.09.001_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.jchf.2013.09.001_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2012.03.076","article-title":"Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"60","author":"Todiere","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.1137325","article-title":"Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy","volume":"316","author":"Kim","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jchf.2013.09.001_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(99)06187-5","article-title":"Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy","volume":"355","author":"Marian","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2013.09.001_bib9","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-\u03b2","volume":"120","author":"Teekakirikul","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jchf.2013.09.001_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2013.09.001_bib11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1253\/circj.69.1244","article-title":"Valsartan decreases type I collagen synthesis in patients with hypertrophic cardiomyopathy","volume":"69","author":"Kawano","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.jchf.2013.09.001_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1536\/ihj.48.715","article-title":"A\u00a0new therapeutic strategy for hypertrophic nonobstructive cardiomyopathy in humans. A randomized and prospective study with an Angiotensin II receptor blocker","volume":"48","author":"Yamazaki","year":"2007","journal-title":"Int Heart J"},{"key":"10.1016\/j.jchf.2013.09.001_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2353\/jmoldx.2009.080082","article-title":"The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study","volume":"11","author":"Penicka","year":"2009","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jchf.2013.09.001_bib14","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.amjcard.2005.07.065","article-title":"Effect of losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy","volume":"96","author":"Araujo","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2013.09.001_bib15","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.09.001_bib16","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-dependent regression of\u00a0myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"D\u00edez","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2013.09.001_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2009.08.010","article-title":"Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma\u2014the Presage ST2 assay","volume":"409","author":"Dieplinger","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jchf.2013.09.001_bib18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/eurjhf\/hfq091","article-title":"Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure","volume":"12","author":"Shah","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2013.09.001_bib19","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification","volume":"18","author":"Lang","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jchf.2013.09.001_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh","year":"2009","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jchf.2013.09.001_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1148\/radiol.10090526","article-title":"Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging","volume":"258","author":"Harrigan","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.jchf.2013.09.001_bib22","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","article-title":"The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"43","author":"Moon","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.09.001_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.09.001_bib24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","article-title":"Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy","volume":"56","author":"Bruder","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.09.001_bib25","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.jacc.2004.09.005","article-title":"Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice","volume":"44","author":"Lutucuta","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2013.09.001_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jcmg.2012.09.018","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR","volume":"6","author":"Moravsky","year":"2013","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.jchf.2013.09.001_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N\u00a0Engl J Med"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177913003144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177913003144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T06:52:45Z","timestamp":1539240765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177913003144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2213177913003144"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2013.09.001","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}